Use of antiplatelet agents in the management of thrombotic disorders
- PMID: 8317139
- PMCID: PMC1022086
Use of antiplatelet agents in the management of thrombotic disorders
Comment on
-
Antiplatelet therapy--Part I.West J Med. 1993 Apr;158(4):385-92. West J Med. 1993. PMID: 8317125 Free PMC article. Review.
Similar articles
-
Survival of heparins, oral anticoagulants, and aspirin after the year 2010.Semin Thromb Hemost. 2008 Feb;34(1):58-73. doi: 10.1055/s-2008-1066025. Semin Thromb Hemost. 2008. PMID: 18393143 Review.
-
Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?Int Angiol. 2008 Jun;27(3):176-92. Int Angiol. 2008. PMID: 18506123 Review.
-
Preventive cardiology: what is the value of antiplatelet agents and fish oils?South Med J. 1988 Sep;81(9):1145-50. South Med J. 1988. PMID: 3047882 Review. No abstract available.
-
[Prevention of cardiovascular events with antiplatelet drugs: aspirin (and others)?].Minerva Cardioangiol. 1999 Nov;47(11):389-90. Minerva Cardioangiol. 1999. PMID: 10641409 Italian. No abstract available.
-
Antiplatelet therapy with aspirin: from clinical trials to practice.Thromb Haemost. 1995 Jul;74(1):401-5. Thromb Haemost. 1995. PMID: 8578495 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical